TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Achillion Pharmaceuticals
Curated by ChEMBL
Achillion Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.10E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Achillion Pharmaceuticals
Curated by ChEMBL
Achillion Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of human ERG expressed in mammalian cells by patch clamp methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Achillion Pharmaceuticals
Curated by ChEMBL
Achillion Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >3.00E+4nMAssay Description:Inhibition of human ERG expressed in mammalian cells by patch clamp methodMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Achillion Pharmaceuticals
Curated by ChEMBL
Achillion Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.24E+5nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair